© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 23, 1764-1765,
December 5, 2001
© 2001 Oxford University Press
EDITORIAL |
Hormone Replacement Therapy and Adenoma Recurrence: Implications for Its Role in Colorectal Cancer Risk
Correspondence to: María Elena Martínez, Ph.D., Arizona Cancer Center and College of Public Health, University of Arizona, 1515 N. Campbell Ave., Tucson, AZ 85724 (e-mail: emartinez@azcc.arizona.edu).
In this issue of the Journal, Woodson et al. (1) present findings on the role of hormone replacement therapy (HRT) and the risk of adenoma recurrence from a prospective study nested in the Polyp Prevention Trial (PPT). Their results show that current HRT use is not associated with recurrence of adenomatous polyps. However, the investigators did observe a statistically significant interaction by age. Among women aged 62 years and older, an inverse association between HRT use and the risk of adenoma recurrence was shown (odds ratio [OR] = 0.58; 95% confidence interval [CI] = 0.35 to 0.97), whereas among women aged
REFERENCES
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. T. Jacobs, M. E. Martinez, and D. S. Alberts Research and Public Health Implications of the Intricate Relationship Between Calcium and Vitamin D in the Prevention of Colorectal Neoplasia J Natl Cancer Inst, December 3, 2003; 95(23): 1736 - 1737. [Full Text] [PDF] |
||||
![]() |
M. E. Martinez, T. G. O'Brien, K. E. Fultz, N. Babbar, H. Yerushalmi, N. Qu, Y. Guo, D. Boorman, J. Einspahr, D. S. Alberts, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene PNAS, June 24, 2003; 100(13): 7859 - 7864. [Abstract] [Full Text] [PDF] |
||||

